Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia

Clinical Endocrinology

Volumn 45, Issue 5, 1996, Pages 535-541

  Guo, C Y ^a   Weetman, A P ^a   Eastell, R ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ANDROSTENEDIONE; COLLAGEN DERIVATIVE; CORTICOSTEROID; CORTISONE ACETATE; DEXAMETHASONE; HYDROCORTISONE; HYDROXYPROGESTERONE; OSTEOCALCIN; PRASTERONE SULFATE; PREDNISOLONE; STEROID 11BETA MONOOXYGENASE; STEROID 21 MONOOXYGENASE;

ADULT; AGED; ARTICLE; BONE MINERAL; BONE TURNOVER; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; FEMALE; HORMONE DEFICIENCY; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029826075     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.00851.x     Document Type: Article

References (42)

1. Antony, G. (1984) Management of congenital adrenal hyperplasia. Lancet, 1, 1073.
2. Appan., S., Hindmarsh., P.C. & Brook., C.G.D (1989) Monitoring treatment in congenital adrenal hyperplasia. Archives of Disease in Childhood, 64, 1235-1239.
3. Azziz, R., Dewailly, D. & Owerbach, D. (1994) Nonclassic adrenal hyperplasia: current concepts. Journal of Clinical Endocrinology and Metabolism, 78, 810-815.
4. Bartter, F.C., Forbes, A.P. & Leaf, A. (1950) Congenital adrenal hyperplasia associated with the adrenogenital syndrome: an attempt to correct its disordered hormonal pattern. Journal of Clinical Investigation, 29, 797-800.
5. Cameron, F.J., Daymakci, B., Byrt, E.A., Ebeling, P.R., Warne, G.L. & Wark, J.D. (1995) Bone mineral density and body composition in congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 80, 2238-2243.
6. De La Piedra, C., Torres, R., Rapado, A., Diaz Curiel, M. & Castro, N. (1989) Serum tartrate-resistant acid phosphatase and bone mineral content in postmenopausal osteoporosis. Calcified Tissue International, 45, 58-60.
7. Delmas, P.D. (1993) Biochemical markers of bone turnover. Jounal of Bone and Mineral Research, 8, s549-s555.
8. Dempster, D.W., Arlot, M.A. & Meunier, P.J. (1983) Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcified Tissue International, 35, 410-417.
9. Duck, S.C. (1980) Acceptable linear growth in congenital adrenal hyperplasia. Journal of Pediatrics, 97, 93-96.
10. Eastell, R. (1994) Biochemical markers. Spine, 8, 155-170.
11. Eastell, R. (1995) Management of corticosteroid-induced osteoporosis. Journal of Internal Medicine, 237, 439-447.
12. Egan, S.M., Betts, P., Thomson, S., Wallace, A.M. & Wood, P.J. (1989) A bloodspot androstenedione assay suitable for home-monitoring of steroid replacement therapy in congenital adrenal hyperplasia. Annals of Clinical Biochemistry, 26, 262-267.
13. Finkelstein, J.S., Neer, R.M., Biller, B.M.K., Crawford, J.D. & Klibanski, A. (1992) Osteopenia in men with a history of delayed puberty. The New England Journal of Medicine, 326, 600-604.
14. Garnero, P., Gineyts, E., Arbault, P., Christiansen, C. & Delmas, P.D. (1995) Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-link excretion. Journal of Bone and Mineral Research, 10, 641-649.
15. Hall, G.M., Perry, L.A. & Spector, T.D. (1993) Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density. Annals of Rheumatic Diseases, 52, 211-214.
16. Hanson, D.A., Weis, M.A.E., Bollen, A., Maslan, S.L., Singer, F.R. & Eyre, D.R. (1992) A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked n-telopeptides in urine. Journal of Bone and Mineral Research, 7, 1251-1258.
17. Hughes, I.A. (1987) Steroids and growth. British Medical Journal, 295, 683-684.
18. 3 modulates glucocorticoid-induced alteration in serum bone Gla protein and bone histomorphometry. Endocrinology, 120, 531-536.
19. Jowsey, J. & Riggs, B. L. (1970) Bone formation in hypercortisolism. Acta Endocrinologies, 63, 21-28.
20. Klingensmith, G.J., Garcia, C.G., Jones, H.W., Migeon, C.J. & New, M.I. (1977) Glucocorticoid treatment of girls with congenital adrenal hyperplasia: Effects on height, sexual maturation and fertility. Journal of Pediatrics, 90, 996-1004.
21. Korth-Schutz, S., Virdis, R., Saenger, R., Chow, D.M., Levine, L.S. & New, M.I. (1978) Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 46, 452-458.
22. Linder, B., Feuillan, P & Chrousos, G.P. (1989) Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth. Journal of Clinical Endocrinology and Metabolism, 69, 191-195.
23. 3. Clinical Orthopedics and Related Research, 181, 264-268.
24. Lisa, L., Neradilova, M., Tomasova, N., Soutorova, M. & Zimak, J. (1995) Osteocalcin in congenital adrenal hyperplasia. Bone, 16, 57-59.
25. Lukert, B.P. & Raisz, L.G. (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Annals of Internal Medicine, 112, 352-364.
26. Montecucco, C., Caporali, R., Caprotti, P., Caprotti, M. & Notario, A. (1992) Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids. Journal of Rheumatology, 19, 1895-1900.
27. Mora, S., Weber, G., Saggion, F., Russo, G., Prinster, C., Proverbio, M.C. & Chiumello, G. (1995) Effect of long-term glucocorticoid therapy on bone density and bone remodeling indexes in patients with congenital adrenal hyperplasia. Bone, 16, 137 s (abstract).
28. Murphy, S., Khaw, K.T., Sneyd, M.J. & Compston, J.E. (1992) Endogenous sex hormones and bone mineral density among community-based postmenopausal women. Postgraduate Medical Journal, 68, 908-913.
29. Pedrazzoni, M., Fantuzzi, M., Alfano, F.S., Gatti, C., Girasole., G., Giuliani, N., Camopanini, C. & Passeri., M. (1995) Urinary cross-linked N-telopeptides of type I collagen: A sensitive marker reflecting disease activity and the efficacy of bisphosphonate treatment in Paget's disease. Bone, 16, 212 s (abstract).
30. Rappaport, R., Cornu, G. & Royer, P. (1968) Statural growth in congenital adrenal hyperplasia treated with hydrocortisone. Journal of Pediatrics, 73, 760-766.
31. Reid, I.R. (1989) Pathogenesis and treatment of osteoporosis. Clinical Endocrinology, 30, 83-103.
32. Riordan, F.A.I., Wood, P.J., Wakelin, K., Betts, P. & Clayton, B.E. (1984) Blood spot 17-hydroxyprogesterone radioimmunoassay for diagnosis of congenital adrenal hyperplasia and home monitoring of corticosteroid replacement therapy. Lancet, i, 708-710.
33. Rosalki, S.B. & Foo, A.Y. (1984) Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clinical Chemistry, 30, 1182-1186.
34. rd ed, WB Saunders Company, Philadelphia, 1995, p. 2554.
35. Sambrook, P.N., Eisman, J.A., Champion, E.D. & Pocock, N.A. (1988) Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheumatology, 31, 973-978.
36. Sambrook, P.N., Birmingham, J., Kempler, P.K., Eberl, S., Pocock, N., Yeates, M. & Eisman, J. (1990) Corticosteroid effects on proximal femur bone loss. Journal of Bone and Mineral Research, 5, 1211-1216.
37. Smith, R., Donald, R.A., Espiner, E.A., Glathaar, C., Abbott, G. & Scandrett, M. (1980) The effect of different treatment regimens on hormonal profiles in congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 51, 230-236.
38. Spector, D.T., Thompson, P.W., Perry, H.H., McGarrigle & Edwards, A.C. (1991) The relationship between sex steroids and bone mineral content in women soon after the menopause. Clinical Endocrinology, 34, 37-41.
39. Stein, J.A., Lazewatsky, J.L. & Hochberg, A.M. (1987) Dual energy x-ray bone densitometer incorporating an internal reference system. Radiology, 170, 817-822.
40. Traverso, A., Boccignone, E., Panganelli, P., Regesta, G., Ottonello, G.A. & Giordano., G. (1995) Bone resorption in epileptic patients on chronic treatment assessed by the measurement of urinary pyridinium cross-links and urinary crosslinked N-telopeptedes of bone type I collagen. Bone, 16 (supplement). s108 (abstract).
41. Winterer, J., Chrousos, G.P., Loriaux, D.L. & Cutler, B.G. (1985) Effect of hydrocortisone dose schedule on adrenal steroid secretion in congenital adrenal hyperplasia. Journal of Pediatrics, 106, 137-142.
42. Youg, M.C., Ribeiro, J. & Hughes., I.A. (1989) Growth and body proportions in congenital adrenal hyperplasia. Archives of Disease in Childhood, 64, 1554-1558.